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Abstract: This study examined whether multi-disciplinary health care providers (HCPs) perceived race of 
persons with sickle cell disease (SCD) as an influence in the delivery of health care. A total of 227 
multidisciplinary HCPs completed the three-item Influence of Patient Race on Provision of Health Care 
Services Index (Cronbach's alpha = = 0.77). Results suggest that African American HCPs were more likely 
to perceive race as an influence along all scale items, whereas Caucasian and other race HCPs did not. 
Female HCPs and those who serve adults were more likely than male HCPs and those who serve children to 
perceive race as having an influence on the quality of health care. Findings suggest a need for the 
examination of the health care delivery systems in which persons with SCD receive care to determine if race 
does, in fact, affect the delivery of health care and to explain the discrepancies in the perceptions of the 
HCPs. 
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Article: 
One of three overarching goals for the nation outlined in Healthy People 2000
1 
is to reduce health disparities 
among Americans. Since the United States began to collect race-specific health data 50 years ago, health 
differences between African Americans and other Americans have been noted. An often, discussed but rarely 
studied clinical issue is how the race of persons with sickle cell disease (SCD) influences the type and 
quality of care they receive. Epidemiological studies examining these differences have concluded that race is 
a major risk factor even after other socioeconomic factors are controlled. Evidence also indicates that 
characteristics ascribed to being African American, such as being poor or violence prone, influence provider 
decision making and behaviors.
2,3 
 
The discrimination in the health care system faced by African Americans is a function of biases against 
poverty and race.
4-5
 Chamberlain
6
 argues that that the majority group's views are based on negative "implied 
causes" that are stereotypical misconceptions about the social and health practices of African Americans. 
These views have led to institutionalized racism and classism. Gamble
7
 notes that medicine is not a value-
free discipline; rather, it reflects and reinforces the beliefs, values, and power dynamics of the wider society 
in both its policies and practices. Such practices serve to reinforce the constellation of mistrustful attitudes 
and beliefs about the medical care system generally held by people of color.
3-5
 These attitudes have 
contributed to the negative health and medical care of many people of color within the health care system, 
which in turn influence their health behavior.
8-10
 For example, persons who are ethnically and culturally 
different from health and medical care providers often do not follow through on prescribed medical regimens 
they do not trust.
11-13
 
 
A related problem is the belief among many people of color that health and medical care providers are not 
really interested in them or their health.
13
 Blendon and colleagues
14
 found that that African Americans were 
more likely than whites to report that during their most recent visit their doctor did not inquire sufficiently 
about their pain or symptom, tell them how long it would take for prescribed medicine to work, explain the 
severity of the illness, or discuss examination findings. 
Because SCD occurs most often in African Americans in the United States, the role of race in the delivery of 
care to persons with this condition is an important issue.
15
 Currently, about 65,000 individuals with SCD 
reside in the United States.
16
 It is the most common genetic disorder within a specific population, having an 
incidence of 1 in every 500 live blackbirths.
17-18
 Recent results from the Cooperative Study of Sickle Cell 
Disease (CSSCD) show that for individuals with the most common and severe form of SCD (hemoglobin 
SS), the median age of death was 42 years for males and 48 years for females; and, for those with the second 
most common and milder form (hemoglobin SC), the median age of death was 60 years for males and 68 for 
females (similar to the general population of African Americans).
15-18
 
 
Many persons with SCD must deal with lack of knowledge and understanding of their condition by providers 
and the general public, the stereotype of being socially dysfunctional as a result of having a chronic 
condition, and the stigmatization of their condition as the "black disease."
15
 In addition to managing a 
chronic condition like SCD, these individuals must also struggle with issues related to being African 
American, as well as being a member of a racial group with high rates of poor health and social outcomes 
(e.g., violence, school dropout and teenage pregnancy).
19-21
 
 
Anecdotal evidence suggests that it is the association with being African American and the chronicity of 
SCD that may account for much of the disparity in type and quality of care received by persons with SCD. 
However, the evidence also indicates that there is not consensus among SCD and other providers that patient 
race affects the delivery of care. Because this important issue has not been addressed in the research and 
clinical practice literature, many questions remain unanswered. The research presented in this article 
attempts to address these questions. Specifically, it asks the following: (1) Are there specific clinical care 
areas in which race of the person influences the type and quality of care as perceived by health care 
providers? and (2) What characteristics of the provider are associated with the perception that the race of the 
persons with SCD influences the type and quality of care? 
 
To address these questions, a cross-sectional study was carried out in 1993 by a multidisciplinary team of 
clinicians and researchers at the University of North Carolina at Chapel Hill (UNC). The purpose of this 
study was to examine whether multidisciplinary health care providers perceive the race of persons with SCD 
as influencing their health and medical care. This study was part of a larger study examining the issues, 
concerns, and expectations of health care providers with regard to the problem of transition of adolescents 
and young adults to adult carecare.
22 
 
Methods 
A total of 227 multidisciplinary health and medical care providers completed the provider version of the 
Sickle Cell Transfer Questionnaire (SCTQ) (discussed elsewhere22). All SCTQ questions were developed 
specifically for the larger study and were based on patient/parent clinical concerns expressed in individual 
clinic encounters, three focus group sessions with direct health care providers (psychosocial and biomedical) 
over a two-year period, and concerns expressed by a cadre of 12 clinicians and researchers from the 
Duke/UNC Comprehensive Pediatric and Adult SCD Programs and their community-based affiliates. 
Although the SCTQ was primarily concerned with issues of adolescent transition, the three items examined 
in this article were asked about the SCD population as a whole. Multidisciplinary health care providers who 
participated in the study were recruited from the Duke/UNC Comprehensive Sickle Cell Program and its 
satellites and community-based affiliates; a random sample of private providers from the state of North 
Carolina, who, because of their specialty area (e.g., internal medicine) had the potential of treating persons 
with SCD; and a national sample of providers who treat persons with SCD (taken from the National Heart, 
Lung and Blood Institute roster of SCD providers) (see Table 1). 
 
The provider version of the three-item Influence of Patient Race on Provision of Health Care Services Index 
(IPR-PHCSI, developed specifically for this study) was included in the SCTQ. Using methods discussed by 
Spedor
23
 and DeVellis 
24
 the IPR-PHCSI assessed participants' underlying perceptions about the influence of 
race on the provision of care. It also allowed for a clearer examination of the tendency of responses to the 
three items to be highly correlated in the initial bivariate analysis. The participants were asked to agree 
(scored as 1) or disagree (scored as 0) with three critical questions about (1) the quality of health care 
provided to persons with SCD, (2) decisions about the administration of pain medication to persons with 
SCD, and (3) the quality of interpersonal relations between health care providers and persons with SCD (see 
the appendix). The lowest possible score for the IPR-PHCSI was 0, and the highest possible score was 3.3. 
Internal consistency of the IPR-PHCSI, as assessed by Cronbach's alpha, was 0.77. The present study is an 
examination of the three individual items and the overall index. 
 
 
 
Analyses were conducted at both univariate and bivariate levels. Simple bivariate statistics were used to 
examine between- and within-group associations of key descriptive and categorical variables (e.g., race, age, 
gender, and specialty type, respectively). Because it was important to ascertain the perceived level of 
agreement among providers by category, dummy variables (e.g., 1 = pediatrician, 0 = nonpediatrician) 
representing the key provider characteristics of race, gender, primary specialty population served and 
regional location were, location were developed and used in the bivariate analysis 
 
As indicated in Hosmer and Lemeshow,
25
 because of the sample size and dichotomous outcome variable 
(perception of race as an influence), multivariate logistic regression analyses of the individual items were 
conducted. Based on the same rationale, multiple linear regression of the overall index was conducted. The 
purpose of these analyses was to determine the strongest predictors (independent variables) that best clarify 
the statistically significant (p< 0.1) bivariate results. All analyses were carried out using SPSS/PC+.
26
 
 
 
 
Results 
Demographic characteristics of the sample are listed in Table 1. 1. Individual item results at the univariate 
level indicate that that health care providers generally disagreed that race influences the delivery of health 
care to individuals with SCD (Table 2). 
 
Health care providers especially did not agree (77 percent) that decisions about pain medications are 
influenced by the race of their patients. However, the bivariate results indicate that responses to these 
questions varied by the provider characteristics of race, gender, specialty, population served, and regional 
location (Table 3). Bivariate results comparing responses to these questions of providers who had a primary 
treatment focus on persons with SCD (comprehensive centers [44percent]versus versus those who did not 
have this focus, e.g., private practice, health departments, etc. [66 percent]), and results comparing providers 
who were in hospital inpatient/outpatient settings [56 percent] versus those in community-based settings 
were not statistically significant and, therefore, will not be discussed here or listed in T able 3). 
 
Provider race-ethnicity. Bivariate results indicated that African American providers were more likely to 
agree with all questions than were both Caucasians and non-African Americans. African American providers 
were significantly more likely to agree that race is an influence on quality (76 percent, p < 0.00), whereas 
Caucasians were less likely to agree that race is an influence on quality (35 percent, p < 0.00) in the 
provision of healthcare care services for African Americans with SCD (Table 3). 
 
Gender of provider. The bivariate results also reveal that that gender is a factor influencing provider 
perspectives on these questions. Female health care providers were significantly more likely than male 
providers to agree with all three statements regarding race as an influence on the provision of health care for 
African Americans with SCD (30 to 54 percent females vs. vs. 12 to 37 percent males, males, p = 0.01 or 
less) (Table 3). 
 
Provider specialty. Table 3 indicates that with regard to the question of the effect of race on the quality of 
health care received by African Americans, internists were more likely to agree that race is an influencing 
factor (72 percent, p < 0.09) than were their colleagues. Pediatricians, on the other hand, were more likely 
than other types of providers to disagree that the quality of health care is affected by race (66 percent, p < 
0.07). The bivariate results confirmed the univariate results that regardless of specialty, providers tended to 
disagree that decisions about pain medication are influenced by the fact that patients are predominantly 
African American. Pediatricians were significantly less likely to agree (9 percent, p <0.02), whereas social 
workers/counselors were significantly more likely to agree than other health care providers (37 percent, p 
<0.01). Similarly, on the question of the effect of race on the quality of interpersonal relations between 
providers and patients, pediatricians were again least likely to agree (29 percent, p < 0.01) than other health 
care providers, whereas social workers/counselors counselors were more likely to agree (60 percent, p < 
0.06). 
 
 
Type of population served. Results in Table 3 show that that providers who serve adults were much more 
likely than those who serve children to agree that race influences the quality of health and medical care (63 
percent, p = 0.3), the administration of pain medications (39 percent, p = 0.01), and the quality of 
provider/patient relations. 
 
Regional location. Results in Table 33 show that providers in urban and rural areas differed only on the 
question of the administration of pain medication. Providers in urban locations were more likely than 
providers in rural areas to agree that race of the patient influences pain medication decisions (26 vs. 11 
percent, p < 0.02). 
 
In summary, providers who were African American, were female, were not pediatricians, treated adult 
patients only, and worked in urban areas were more likely to perceive race as an influence in the provision of 
health and medical care to persons with SCD. Multivariate analyses were conducted to clarify which 
provider characteristic(s) had the greatest influence on the respondents' beliefs. Given the study's small 
sample size, all of the provider characteristics that were statistically significant at the bivariate level(p < 0.1) 
were entered into a set of multiple regression models to avoid omitting important variables. Logistic 
regression models
25
 were used to examine agreement or disagreement with each of the three individual index 
items, items, whereas multivariate linear regression models
27
 were used to assess the overall response trend 
of providers (the index score) (Table 4A). 
 
Race of the provider (African American) remained significantly related to all three questions (p < 0.00). For 
quality of health and medical care received, received, population served (adults) also remained significant (p 
= 0.05). For pain medication administration decisions, both population served (adults) and gender (female) 
remained significant (p < 0.05, respectively) (Table 4). For all individual items, provider race (African 
American) was the strongest single predictor of the likelihood of agreement that race was an influence (p < 
0.00), whereas provider race (African American) and provider gender (female) were the strongest overall 
(index score) predictors of agreement (p ≤ 002) (Table 4B) 
 
 
 
 
 
Finally, it is important to note that the IPR-PHCSI items were worded in such a way as not to imply either a 
negative or positive influence of race but to allow for individual interpretation by the respondent. Anecdotal 
provider comments indicated that they perceived the race of the person as negatively influencing the 
provision of care. Examples of these comments are as follows: "Overall I agree; however, it depends a lot on 
caregivers individually"; "These factors should not be true—it is most unfortunate they're due to ignorance"; 
"I do not feel that these issues apply to our clinic; however, unfortunately I do feel that throughout the house 
staff, some of these [statements] may in fact be true"; and "In our program, in ERs, other hospitals, and so 
on, I would 'agree' to all three [statements]." The following discussion will take these comments and the 
interpretation of patient race as a negative influence into account. 
 
Discussion 
Data from this study suggest that while providers in general do not view race as influencing the delivery of 
health and medical care to persons with SCD, there are clear indications that particular groups do feel this 
way, and as the anecdotal evidence indicates, this influence is perceived as negative. The exception was the 
strong agreement on the delivery of pain medications. Pain is related to technical decision making about the 
delivery of prescribed care. It can be argued that it is less individualized and more routinized, thus higher 
levels of agreement would be found, particularly among specialists. However, with regard to the quality of 
care and interpersonal relations between provider and patient, some variation maybe expected because of the 
potential effect of personal biases, individual beliefs, and social influences on decision making and beliefs 
about the population. Furthermore, these factors require a deeper level of listening, communicating, and 
empathy that that are also subject to personal and social influences. The extent of these variations has 
significant implications for the delivery of care to persons with chronic conditions like SCD, because care of 
this population requires not only technical expertise but a need to maintain a long-term interpersonal 
relationship, the monitoring of a regimen of comprehensive (quality) care, and for the provider to demon-
strate an adequate level of cultural competence. 
 
Of all the provider characteristics, African American and Caucasian health and medical care providers had 
opposing views about the effect of race on the delivery and quality of health care for African Americans with 
SCD. This suggests a lack of understanding and communication between the two groups, as well as their 
differential health and medical care experiences. African American and female health care providers (of all 
races) were more likely to believe that race has an influence on the quality of care received, pain medication 
decisions, and interpersonal relations. But the group that that most often serves individuals with SCD—
namely, Caucasian and male health care providers—were less likely to believe that race influenced the 
delivery of health and medical care. Thus, providers who historically have experienced discrimination are 
more likely to perceive that race negatively influences care. This is most likely due to the African American 
and female providers' heightened sensitivity to discrimination as practiced in the health and medical care 
systems. Furthermore, given the tone of the anecdotal remarks, it is most likely true that providers who have 
chosen to work with this population have made a conscious decision to work with a predominantly African 
American population and therefore do not view the race of the patient as a personal issue but they are aware 
that it is a problem outside of their practice. Interestingly, pediatricians were least likely to view race as an 
influence in the provision of health and medical care to persons with SCD. This is most likely due to their 
overall orientation and training, as well as many of the reasons already discussed. 
 
Because of the cross-sectional nature of this study, the overrepresentation of female providers, and the 
sample size, results of this study must be seen as preliminary. Future research should use a more 
representative and randomly selected sample of respondents, especially adult and rural providers. 
Furthermore, it is believed that this study would have been strengthened methodologically if responses had 
been sought to a series of situational questions or scenarios specifically focusing on the relationship between 
patient race and service delivery. Therefore, to determine if race in fact affects the delivery of medical care 
and to explain the discrepancy in the perceptions of female, African American, and Caucasian health care 
providers according to sex and race,
5
 a logical next step would be a rigorous and systematic study using a 
series of situation-specific questions that examine the actual quality and type of care offered by providers 
who serve persons with SCD. 
 
Despite limitations, these findings are consistent with other reports
1-4,6
 and provide support for the anecdotal 
evidence that suggests that race of persons with SCD influences the type and quality of care they receive. 
Even these preliminary findings suggest that physicians, nurses, nurses, physician assistants, and other 
multidisciplinary providers caring for persons with SCD can play a major role in addressing these issues by 
participating in the development and implementation of continuing education programs that increase 
providers' awareness of their own disease, race, ethnic background, gender beliefs, and prejudices. Providers 
can also work with others to build and maintain a culturally diverse and aware staff (inducting scientists and 
administrators) who are sensitive to the disease management issues of persons with SCD and develop 
mechanisms that facilitate understanding and communication between patients from diverse cultural and 
ethnic backgrounds and the health care providers who serve them. 
 
It is essential that health and medical care providers and researchers who care for and study African 
Americans with SCD take into account and address the ramifications of race, culture class gender, and the 
chronicity of the condition as factors affecting health, care delivery. This is particularly important because 
the majority of researchers and physicians providing care for individuals with SCD are Caucasian and male 
and the majority of individuals with SCD are African American. 
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